Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (331-340 of 940) with videos related to

Pageof 94
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Mechanisms of chemoresistance to alkylating agents in malignant gliomaJann N Sarkaria, Gaspar J Kitange, C David James, et al.
Neurology|February 19, 2014
Clinical reasoning: a 30-year-old woman with recurrent seizures and a cerebral lesion progressing over 2 decadesMichaela Tonder, Elisabeth Jane Rushing, Michael Grotzer, et al.
Cellular Microbiology|July 6, 2006
Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1Heike Grassmé, Jianmin Jin, Barbara Wilker, et al.
European Journal of Immunology|October 3, 2006
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNABirgit Scheel, Steffen Aulwurm, Jochen Probst, et al.
Neuro-Oncology Practice|October 5, 2020
Antidepressant drug use in glioblastoma patients: an epidemiological viewDorothee Gramatzki, James Louis Rogers, Marian Christoph Neidert, et al.
Journal of Neurochemistry|October 17, 2019
Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma modelsCaroline von Achenbach, Michael Weller, Kerstin Kaulich, et al.
Journal of Neuroimmunology|January 18, 2005
Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosisMeike Mitsdoerffer, Bettina Schreiner, Bernd C Kieseier, et al.
Journal of Cell Science|November 22, 2017
TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cellsElisa Ventura, Michael Weller, Will Macnair, et al.
Science Translational Medicine|October 8, 2020
Immunocytokines are a promising immunotherapeutic approach against glioblastomaTobias Weiss, Emanuele Puca, Manuela Silginer, et al.
Neuro-Oncology Practice|August 7, 2019
Glioblastoma in the elderly: making sense of the evidenceMatthew Mason, Normand Laperriere, Wolfgang Wick, et al.
Pageof 94

Showing results (331-340 of 940) with videos related to

Sort By:
Pageof 94
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Mechanisms of chemoresistance to alkylating agents in malignant gliomaJann N Sarkaria, Gaspar J Kitange, C David James, et al.
Neurology|February 19, 2014
Clinical reasoning: a 30-year-old woman with recurrent seizures and a cerebral lesion progressing over 2 decadesMichaela Tonder, Elisabeth Jane Rushing, Michael Grotzer, et al.
Cellular Microbiology|July 6, 2006
Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1Heike Grassmé, Jianmin Jin, Barbara Wilker, et al.
European Journal of Immunology|October 3, 2006
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNABirgit Scheel, Steffen Aulwurm, Jochen Probst, et al.
Neuro-Oncology Practice|October 5, 2020
Antidepressant drug use in glioblastoma patients: an epidemiological viewDorothee Gramatzki, James Louis Rogers, Marian Christoph Neidert, et al.
Journal of Neurochemistry|October 17, 2019
Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma modelsCaroline von Achenbach, Michael Weller, Kerstin Kaulich, et al.
Journal of Neuroimmunology|January 18, 2005
Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosisMeike Mitsdoerffer, Bettina Schreiner, Bernd C Kieseier, et al.
Journal of Cell Science|November 22, 2017
TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cellsElisa Ventura, Michael Weller, Will Macnair, et al.
Science Translational Medicine|October 8, 2020
Immunocytokines are a promising immunotherapeutic approach against glioblastomaTobias Weiss, Emanuele Puca, Manuela Silginer, et al.
Neuro-Oncology Practice|August 7, 2019
Glioblastoma in the elderly: making sense of the evidenceMatthew Mason, Normand Laperriere, Wolfgang Wick, et al.
Pageof 94